Pharmasaga Co. Ltd. (TPEX:7878)
299.50
0.00 (0.00%)
At close: Feb 11, 2026
Pharmasaga Statistics
Total Valuation
Pharmasaga has a market cap or net worth of TWD 16.03 billion. The enterprise value is 15.86 billion.
| Market Cap | 16.03B |
| Enterprise Value | 15.86B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Pharmasaga has 53.54 million shares outstanding.
| Current Share Class | 53.54M |
| Shares Outstanding | 53.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.50% |
| Owned by Institutions (%) | 7.26% |
| Float | 42.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 61.40 |
| P/TBV Ratio | 86.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -196.05 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.03, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.03 |
| Quick Ratio | 12.75 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,397.04 |
Financial Efficiency
Return on equity (ROE) is -32.86% and return on invested capital (ROIC) is -23.28%.
| Return on Equity (ROE) | -32.86% |
| Return on Assets (ROA) | -22.34% |
| Return on Invested Capital (ROIC) | -23.28% |
| Return on Capital Employed (ROCE) | -35.12% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -8.99M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 273.06 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.77 |
| Average Volume (20 Days) | 436,256 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -91.72M |
| Pretax Income | -80.88M |
| Net Income | -80.88M |
| EBITDA | -84.66M |
| EBIT | -91.72M |
| Earnings Per Share (EPS) | -3.25 |
Balance Sheet
The company has 178.73 million in cash and 259,000 in debt, with a net cash position of 178.47 million or 3.33 per share.
| Cash & Cash Equivalents | 178.73M |
| Total Debt | 259,000 |
| Net Cash | 178.47M |
| Net Cash Per Share | 3.33 |
| Equity (Book Value) | 261.13M |
| Book Value Per Share | 9.26 |
| Working Capital | 168.57M |
Cash Flow
| Operating Cash Flow | -68.99M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Pharmasaga does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.50% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |